The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects
- PMID: 2471710
- DOI: 10.1210/jcem-69-1-151
The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects
Abstract
Polycystic ovarian disease (PCOD) is associated with elevated serum LH and (sub)normal FSH levels, while serum androgen levels are often elevated. To clarify the role of androgens in this abnormal pattern of gonadotropin secretion, LH secretion was studied in 1) 9 eugonadal female to male transsexual subjects before and during long term (6 months) testosterone (T) administration (250 mg/2 weeks, im), and 2) in a woman with an androgen-secreting ovarian tumor both before and after surgical removal of the tumor. Finally, we studied the effects of high serum androgen levels on ovarian histology in 3) 26 transsexual subjects after long term (9-36 months) T administration (250 mg/2 weeks, im) to assess whether T-induced ovarian abnormalities are similar to those that occur in women with PCOD. Long term T treatment in the nine female to male transsexual subjects resulted in increases in the mean serum T level from 1.7 +/- 0.8 (+/- SD) to 40.8 +/- 31.9 nmol/L (P less than 0.01), the mean serum dihydrotestosterone level from 0.6 +/- 0.2 to 3.3 +/- 1.5 nmol/L (P less than 0.02), and the mean serum free T level from 9.5 +/- 5.2 to 149 +/- 46 pmol/L (P less than 0.02). Mean serum estrone and estradiol levels were similar before and during T treatment. The mean serum LH level decreased from 6.3 +/- 2.0 to 2.9 +/- 1.1 U/L (P less than 0.01), and the mean FSH levels decreased from 6.6 +/- 2.0 to 3.7 +/- 2.2 U/L (P less than 0.02). Pulsatile LH secretion before and during T treatment was studied in five subjects. Neither the mean nadir LH interval nor the LH pulse amplitude changed significantly in these five subjects. The serum T level in the woman with the androgen-secreting ovarian tumor was 9.6 nmol/L, and it declined to normal after removal of the tumor. Her mean serum LH and FSH levels, the mean nadir LH interval, and LH pulse amplitude were in the normal range before and after removal of the tumor. Studies of ovarian histopathology in 26 transsexual subjects after long term androgen treatment revealed multiple cystic follicles in 18 subjects (69.2%), diffuse ovarian stromal hyperplasia in 21 subjects (80.8%), collagenization of the tunica albuginea in 25 subjects (96.2%), and luteinization of stromal cells in 7 subjects (26.9%). Findings consistent with criteria for the pathological diagnosis of polycystic ovaries, that is 3 of the 4 findings listed above, were present in 18 of the 26 subjects (69.2%).(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Effects of long-term testosterone administration on gonadotropin secretion in agonadal female to male transsexuals compared with hypogonadal and normal women.J Clin Endocrinol Metab. 1989 Jan;68(1):200-7. doi: 10.1210/jcem-68-1-200. J Clin Endocrinol Metab. 1989. PMID: 2491861
-
Sex steroids and pulsatile luteinizing hormone release in men. Studies in estrogen-treated agonadal subjects and eugonadal subjects treated with a novel nonsteroidal antiandrogen.J Clin Endocrinol Metab. 1987 Apr;64(4):763-70. doi: 10.1210/jcem-64-4-763. J Clin Endocrinol Metab. 1987. PMID: 3102546
-
Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.J Clin Endocrinol Metab. 1988 Feb;66(2):327-33. doi: 10.1210/jcem-66-2-327. J Clin Endocrinol Metab. 1988. PMID: 3123511
-
Endocrinological environment of polycystic ovarian disease.Horm Res. 1990;33 Suppl 2:5-9. doi: 10.1159/000181557. Horm Res. 1990. PMID: 2128882 Review.
-
Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism.Ann N Y Acad Sci. 1993 May 28;687:162-81. doi: 10.1111/j.1749-6632.1993.tb43864.x. Ann N Y Acad Sci. 1993. PMID: 8323171 Review.
Cited by
-
The Mechanism of Androgen Actions in PCOS Etiology.Med Sci (Basel). 2019 Aug 28;7(9):89. doi: 10.3390/medsci7090089. Med Sci (Basel). 2019. PMID: 31466345 Free PMC article. Review.
-
Effect of the spatial-temporal specific theca cell Cyp17 overexpression on the reproductive phenotype of the novel TC17 mouse.J Transl Med. 2021 Oct 15;19(1):428. doi: 10.1186/s12967-021-03103-x. J Transl Med. 2021. PMID: 34654452 Free PMC article.
-
Impact of Exogenous Testosterone on Reproduction in Transgender Men.Endocrinology. 2020 Mar 1;161(3):bqaa014. doi: 10.1210/endocr/bqaa014. Endocrinology. 2020. PMID: 32105330 Free PMC article. Review.
-
REPRODUCTIVE HEALTH IN TRANS AND GENDER-DIVERSE PATIENTS: Gonadal tissue cryopreservation in transgender and gender-diverse people.Reproduction. 2024 Nov 25;168(6):e240253. doi: 10.1530/REP-24-0253. Print 2024 Dec 1. Reproduction. 2024. PMID: 39331789 Free PMC article. Review.
-
A mouse model to investigate the impact of testosterone therapy on reproduction in transgender men.Hum Reprod. 2019 Oct 2;34(10):2009-2017. doi: 10.1093/humrep/dez177. Hum Reprod. 2019. PMID: 31585007 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical